These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 3816603)

  • 1. [Treatment of bone metastases of breast cancer].
    Heimpel H
    Dtsch Med Wochenschr; 1987 Feb; 112(7):286. PubMed ID: 3816603
    [No Abstract]   [Full Text] [Related]  

  • 2. [Criteria for evaluating the efficacy of treatment of breast cancer metastases to the bones].
    Lichinitser MR; Vyshinskaia GV; Gritsaĭ AA; Kondrat'eva AP; Luk'ianchenko AB
    Med Radiol (Mosk); 1986 Feb; 31(2):28-31. PubMed ID: 3951344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic response in breast cancer metastasizing to the bones].
    Elomaa I; Virkkunen P
    Duodecim; 1985; 101(8):771-7. PubMed ID: 3996257
    [No Abstract]   [Full Text] [Related]  

  • 4. [Local treatment of metastatic bone tumors].
    Watanabe H
    Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 2):790-2. PubMed ID: 2188600
    [No Abstract]   [Full Text] [Related]  

  • 5. [Adriablastin (doxorubicin) in the combined chemotherapy of patients with disseminated forms of breast cancer].
    Voznyĭ EK; Besova NS; Kurkina TV; Al'tshtuller IuB
    Antibiotiki; 1984 Jun; 29(6):463-8. PubMed ID: 6476811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of treatment based on endocrine therapy for bone metastasis from breast cancer].
    Sakurai T; Tatematsu H; Yamataka K; Yamamoto T; Kawahara H
    Gan To Kagaku Ryoho; 2001 Dec; 28(13):2029-34. PubMed ID: 11791380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized phase III comparative trial of immediate consolidation with high-dose chemotherapy and autologous peripheral blood progenitor cell support compared to observation with delayed consolidation in women with metastatic breast cancer and only bone metastases following intensive induction chemotherapy.
    Vredenburgh JJ; Madan B; Coniglio D; Ross M; Broadwater G; Niedzwiecki D; Edwards J; Marks L; Vandemark R; McDonald C; Affronti ML; Peters WP
    Bone Marrow Transplant; 2006 Jun; 37(11):1009-15. PubMed ID: 16633363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of advanced breast cancer: How much chemotherapy is enough?
    DiPaola RS; Kaufman A; Mikhail MM
    Semin Oncol; 1996 Jun; 23(3):xv-xxii; discussion xxii-xxiv. PubMed ID: 8658211
    [No Abstract]   [Full Text] [Related]  

  • 9. [Bisphosphonate for treatment of advanced breast cancers].
    Kohno N; Kitazawa S
    Nihon Rinsho; 2000 Apr; 58 Suppl():345-51. PubMed ID: 11026017
    [No Abstract]   [Full Text] [Related]  

  • 10. [A case of breast cancer metastasis to the skin and bone 13 years after, and to the brain 17 years after mastectomy].
    Itoshima T; Yamamoto T; Kasamatsu T; Fujino H; Yamamoto H; Morita Y; Kodama M
    Gan To Kagaku Ryoho; 1997 Aug; 24(10):1331-3. PubMed ID: 9279355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of bone metastases in breast cancer].
    Köhler AH; Dobberstein N; Stoltmann R; Heschel U
    Zentralbl Chir; 1984; 109(7):483-9. PubMed ID: 6203258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sorafenib tosylate and paclitaxel induce anti-angiogenic, anti-tumour and anti-resorptive effects in experimental breast cancer bone metastases.
    Merz M; Komljenovic D; Zwick S; Semmler W; Bäuerle T
    Eur J Cancer; 2011 Jan; 47(2):277-86. PubMed ID: 20863686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of chemotherapy in the treatment of bone metastases of breast cancer].
    Cayla J; Auclerc C; Goldberg D; Darne C; Jacquillat C
    Rev Rhum Mal Osteoartic; 1984 Dec; 51(11):651-6. PubMed ID: 6523016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical evaluation of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) on advanced and recurrent breast cancer. Clinical study group of CMF for breast cancer in Japan].
    Nomura Y; Tominaga T; Adachi I; Koyama H; Fukami A
    Gan To Kagaku Ryoho; 1994 Sep; 21(12):1949-56. PubMed ID: 8085846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combined mitoxantrone therapy for heavily pretreated metastatic breast cancer].
    Yokoe T; Iino Y; Aoyagi H; Maemura M; Sugamata N; Takai Y; Horiguchi J; Ishida T; Morishita Y
    Gan To Kagaku Ryoho; 1993 Jan; 20(1):169-71. PubMed ID: 8422183
    [No Abstract]   [Full Text] [Related]  

  • 16. Breast cancer: metastatic.
    Johnston S; Stebbing J
    Clin Evid; 2002 Jun; (7):1579-602. PubMed ID: 12230774
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bone metastasis of breast cancer. Apropos of a series of 50 cases].
    Vincent-Joyeux F; Bontoux D; Alcalay M; Daban A; Vincent D
    Sem Hop; 1982 Dec; 58(48):2827-31. PubMed ID: 6302849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of chemotherapy on circulating angiogenic factor levels in patients with breast cancer].
    Tang JH; Zhao JH; Gong JP; Qin JW; Pan LQ; Xu ZY
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):210-4. PubMed ID: 17649639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of adriamycin in the treatment of metastatic breast cancer].
    Dymarskiĭ LIu; Sanchakova AV; Aleksandrova GI; Trishkina EA
    Vopr Onkol; 1984; 30(6):67-73. PubMed ID: 6547554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-naïve patients with locally advanced or metastatic breast carcinoma.
    Hsu C; Huang CS; Chao TY; Lu YS; Bu CF; Chen MM; Chang KJ; Cheng AL
    Cancer; 2002 Nov; 95(10):2044-50. PubMed ID: 12412156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.